Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma - authors' reply

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
² Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. khanna.sahil@mayo.edu.

Comment

A Gupta et al. Aliment Pharmacol Ther. 2016 Jan.

. 2016 Jan;43(1):176.

doi: 10.1111/apt.13467.

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
² Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. khanna.sahil@mayo.edu.

No abstract available

Comment on

Systematic review: colitis associated with anti-CTLA-4 therapy.
Gupta A, De Felice KM, Loftus EV Jr, Khanna S. Gupta A, et al. Aliment Pharmacol Ther. 2015 Aug;42(4):406-17. doi: 10.1111/apt.13281. Epub 2015 Jun 15. Aliment Pharmacol Ther. 2015. PMID: 26079306
Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma.
Bossa F, Perri F, Niro G, Parente P, Graziano P, Andriulli A. Bossa F, et al. Aliment Pharmacol Ther. 2016 Jan;43(1):174-5. doi: 10.1111/apt.13451. Aliment Pharmacol Ther. 2016. PMID: 26638939 No abstract available.